HCT is just under the spot light a little given a bad year. They...

HCT is just under the spot light a little given a bad year. They have a very marketable product, there is interest in the stock (look at the volume over the past few days) and the take away from this should be too expect better communication and more importantly, no cash raise for 12 months. The handbrake is still on (understandably) but following decent sales announcements which should hopefully follow, IMO it will see good growth. As someone said already, look at the ZNO chart around their initial growth phase. There were more aggressive pull backs than we've seen here.

I tell you what though, be great to see some more mature individuals posting on this forum. It's like a middle school play ground.